Human intravenous immunoglobulin provides protection against Aβ toxicity by multiple mechanisms in a mouse model of Alzheimer's disease
Authors:
- Johanna MaggaJMJohanna Magga
- Lakshman PuliLPLakshman Puli
- Rea PihlajaRPRea Pihlaja
- Katja KanninenKKKatja Kanninen
- Suvi NeulamaaSNSuvi Neulamaa
- Tarja MalmTMTarja Malm
- Wolfgang HärtigWHWolfgang Härtig
- Jens GroscheJGJens Grosche
- Gundars GoldsteinsGGGundars Goldsteins
- Heikki TanilaHTHeikki Tanila
- Jari KoistinahoJKJari Koistinaho
- Milla KoistinahoMKMilla Koistinaho
Open Access
- 1 January 2010
- journal article
- Published by Springer Nature in Journal of Neuroinflammation
- Vol. 7 (1) , 90
Abstract
Purified intravenous immunoglobulin (IVIG) obtained from the plasma of healthy humans is indicated for the treatment of primary immunodeficiency disorders associated with defects in humoral immunity. IVIG contains naturally occurring auto-antibodies, including antibodies (Abs) against β-amyloid (Aβ) peptides accumulating in the brains of Alzheimer's disease (AD) patients. IVIG has been shown to alleviate AD pathology when studied with mildly affected AD patients. Although its mechanisms-of-action have been broadly studied, it remains unresolved how IVIG affects the removal of natively formed brain Aβ deposits by primary astrocytes and microglia, two major cell types involved in the neuroinflammatory responses.Keywords
This publication has 68 references indexed in Scilit:
- Neuroprotective natural antibodies to assemblies of amyloidogenic peptides decrease with normal aging and advancing Alzheimer's diseaseProceedings of the National Academy of Sciences, 2009
- Identification of a receptor required for the anti-inflammatory activity of IVIGProceedings of the National Academy of Sciences, 2008
- Degradation of fibrillar forms of Alzheimer's amyloid β-peptide by macrophagesNeurobiology of Aging, 2008
- Rapid appearance and local toxicity of amyloid-β plaques in a mouse model of Alzheimer’s diseaseNature, 2008
- Intravenous immunoglobulin (IVIG) protects the brain against experimental stroke by preventing complement-mediated neuronal cell deathProceedings of the National Academy of Sciences, 2007
- Pyrrolidine Dithiocarbamate Activates Akt and Improves Spatial Learning in APP/PS1 Mice without Affecting β-Amyloid BurdenJournal of Neuroscience, 2007
- Activation of Microglia Acidifies Lysosomes and Leads to Degradation of Alzheimer Amyloid FibrilsMolecular Biology of the Cell, 2007
- β-Amyloid infusion results in delayed and age-dependent learning deficits without role of inflammation or β-amyloid depositsProceedings of the National Academy of Sciences, 2006
- Natural oligomers of the amyloid-β protein specifically disrupt cognitive functionNature Neuroscience, 2004
- Proteolytic Degradation of Alzheimer's Disease Amyloid β‐Peptide by a Metalloproteinase from Microglia CellsJournal of Neurochemistry, 1998